This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jul;8(7):464.

doi: 10.1038/nrmicro2396.

New oral HCV drug shows promise

PMID: 21394952
DOI: 10.1038/nrmicro2396

Comment

New oral HCV drug shows promise

Man Tsuey Tse. Nat Rev Microbiol. 2010 Jul.

. 2010 Jul;8(7):464.

doi: 10.1038/nrmicro2396.

Author

PMID: 21394952
DOI: 10.1038/nrmicro2396

No abstract available

PubMed Disclaimer

Comment on

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.
Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, O'Boyle DR 2nd, Lemm JA, Wang C, Knipe JO, Chien C, Colonno RJ, Grasela DM, Meanwell NA, Hamann LG. Gao M, et al. Nature. 2010 May 6;465(7294):96-100. doi: 10.1038/nature08960. Epub 2010 Apr 21. Nature. 2010. PMID: 20410884 Free PMC article. Clinical Trial.

References

1. Antimicrob Agents Chemother. 2005 Apr;49(4):1346-53 - PubMed
1. J Virol. 2010 Jan;84(1):482-91 - PubMed
1. Nature. 2010 May 6;465(7294):96-100 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group